CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on August 5, 2007
Clinical Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.2215/CJN.01190307
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.01190307v1
2/5/984    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franciosi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franciosi, M.
Related Collections
Right arrowRelated Article

Received March 9, 2007
Accepted on May 7, 2007

ORIGINAL ARTICLES

Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study

Monica Franciosi , Fabio Pellegrini , Michele Sacco , Giorgia De Berardis , Maria C.E. Rossi , Giovanni F.M. Strippoli , Maurizio Belfiglio , Gianni Tognoni , Miriam Valentini , Antonio Nicolucci 1, and on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group

Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy


1 To whom correspondence should be addressed. E-mail: nicolucci{at}negrisud.it.


   Abstract

Background and objectives: The objective of this study was to investigate correlates of risk for having microalbuminuria in individuals with one or more cardiovascular risk factors.

Design, setting, participants, & measurements: The study involved 1919 individuals who attended general practice settings, were aged 55 to 75 yr, and did not have a history of cardiovascular events or diabetes but had one or more cardiovascular risk factors. A tree-based regression technique and multivariate analysis were used to identify distinct, homogeneous subgroups of patients with different likelihood of having microalbuminuria; interaction between correlates of microalbuminuria and risk for microalbuminuria was also investigated.

Results: The prevalence of microalbuminuria was 5.9%. Patients who did not have hypertension and had postload glycemia <140 mg/dl showed the lowest prevalence of microalbuminuria (1.9%) and represented the reference class. The likelihood of microalbuminuria was seven times higher in men with hypertension and homeostatic model assessment levels in the upper tertile and four times higher in women with the same characteristics. Individuals with hypertension and lower homeostatic model assessment levels and normotensive individuals with postload glycemia ≥140 mg/dl had a more than three-fold increased likelihood of having microalbuminuria. Treatment with statins was associated with a 54% reduction in the likelihood of having microalbuminuria, whereas levels of triglycerides >150 mg/dl and fibrinogen levels in the upper tertile were associated with a significantly higher risk for microalbuminuria.

Conclusions: The likelihood of having microalbuminuria in a population-based study of elderly individuals is strongly related to the interaction between the components of the metabolic syndrome, particularly hypertension, insulin resistance, and impaired glucose tolerance.


Related Article

Metabolic Syndrome: An Emerging Threat to Renal Function
Eberhard Ritz
Clin. J. Am. Soc. Nephrol. 2007 2: 869-871. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CJASNHome page
E. Rademacher, M. Mauer, D. R. Jacobs Jr, B. Chavers, J. Steinke, and A. Sinaiko
Albumin Excretion Rate in Normal Adolescents: Relation to Insulin Resistance and Cardiovascular Risk Factors and Comparisons to Type 1 Diabetes Mellitus Patients
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Ritz
Metabolic Syndrome: An Emerging Threat to Renal Function
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 869 - 871.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Nephrology.